Add To Cart


 Bibliography

Test | Table of Contents

Update


Azadfard, M., Huecker, M. R., & Leaming, J. M. (2023). Opioid Addiction. In StatPearls. StatPearls Publishing.

Bagg, M. K., Wand, B. M., Cashin, A. G., Lee, H., Hübscher, M., Stanton, T. R., O'Connell, N. E., O'Hagan, E. T., Rizzo, R. R. N., Wewege, M. A., Rabey, M., Goodall, S., Saing, S., Lo, S. N., Luomajoki, H., Herbert, R. D., Maher, C. G., Moseley, G. L., & McAuley, J. H. (2022). Effect of Graded Sensorimotor Retraining on Pain Intensity in Patients With Chronic Low Back Pain: A Randomized Clinical Trial. JAMA, 328(5), 430-439. https://doi.org/10.1001/jama.2022.9930

Calac, A. J., McMann, T., Cai, M., Li, J., Cuomo, R., & Mackey, T. K. (2022). Exploring substance use disorder discussions in Native American communities: a retrospective Twitter infodemiology study. Harm reduction journal, 19(1), 141. https://doi.org/10.1186/s12954-022-00728-z

Calcaterra, S. L., Lockhart, S., Callister, C., Hoover, K., & Binswanger, I. A. (2022). Opioid Use Disorder Treatment Initiation and Continuation: a Qualitative Study of Patients Who Received Addiction Consultation and Hospital-Based Providers. Journal of general internal medicine, 37(11), 2786-2794. https://doi.org/10.1007/s11606-021-07305-3

Dickerson, D. L., D'Amico, E. J., Palimaru, A., Brown, R., Kennedy, D., Johnson, C. L., & Schweigman, K. (2022). Traditions and Connections for Urban Native Americans (TACUNA): Utilizing community-based input to develop an opioid prevention intervention for urban American Indian/Alaska Native emerging adults. Journal of substance abuse treatment, 139, 108764. https://doi.org/10.1016/j.jsat.2022.108764

Frost, M. C., Austin, E. J., Corcorran, M. A., Briggs, E. S., Behrends, C. N., Juarez, A. M., Frank, N. D., Healy, E., Prohaska, S. M., LaKosky, P. A., Kapadia, S. N., Perlman, D. C., Schackman, B. R., Des Jarlais, D. C., Williams, E. C., & Glick, S. N. (2022). Responding to a surge in overdose deaths: perspectives from US syringe services programs. Harm reduction journal, 19(1), 79. https://doi.org/10.1186/s12954-022-00664-y

Greenwald, M. K., Moses, T. E. H., Lundahl, L. H., & Roehrs, T. A. (2023). Anhedonia modulates benzodiazepine and opioid demand among persons in treatment for opioid use disorder. Frontiers in psychiatry, 14, 1103739. https://doi.org/10.3389/fpsyt.2023.1103739

Horn, D. B., Vu, L., Porter, B. R., & Sarantopoulos, K. (2023). Responsible Controlled Substance and Opioid Prescribing. In StatPearls. StatPearls Publishing.

Kelley-Quon, L. I., Cho, J., Barrington-Trimis, J., Kipke, M. D., Clapp, J. D., Krueger, E. A., & Leventhal, A. M. (2022). Longitudinal trajectories of prescription opioid misuse in adolescents. Drug and alcohol dependence, 236, 109470. https://doi.org/10.1016/j.drugalcdep.2022.109470

Khan, A. R., Olatunji, O., Qureshi, D., Metellus, P., & Nkemjika, S. (2022). Accessibility of Treatment Among Women With Opioid Use Disorder: A Brief Review. Cureus, 14(7), e27509. https://doi.org/10.7759/cureus.27509

Kilmer, B., Pardo, B., Pujol, T. A., & Caulkins, J. P. (2022). Rapid changes in illegally manufactured fentanyl products and prices in the United States. Addiction (Abingdon, England), 117(10), 2745-2749. https://doi.org/10.1111/add.15942

Kim, E. J., Hwang, E. J., Yoo, Y. M., & Kim, K. H. (2022). Prevention, diagnosis, and treatment of opioid use disorder under the supervision of opioid stewardship programs: it's time to act now. The Korean journal of pain, 35(4), 361-382. https://doi.org/10.3344/kjp.2022.35.4.361

Oliver, A. P., Adams, Z. W., Ott, C. A., & Agley, J. (2022). Promoting best practices for managing opioid overdoses in the field: A novel project Extension for Community Healthcare Outcomes program for first responders. Preventive medicine reports, 30, 102038. https://doi.org/10.1016/j.pmedr.2022.102038

Riddle, J., Botsford, J. A., Dean, S., Coffman, C., Robinson, C. A., & Kerver, J. M. (2023). Pain Management After Cesarean Delivery Among Women with Opioid Use Disorder: Results from a Retrospective Pregnancy Cohort in a Rural Region of the Midwest. Women's health reports (New Rochelle, N.Y.), 4(1), 154-161. https://doi.org/10.1089/whr.2022.0108

Rubel, S. K., Neubert, P., Navarretta, N., & Logan, S. (2022). Facilitating Overdose Risk Mitigation Among Patients Following a Clinician Office Closure: A Connecticut Case Study of the Opioid Rapid Response Program. Journal of public health management and practice : JPHMP, 28(Suppl 6), S381-S387. https://doi.org/10.1097/PHH.0000000000001555

Swartz, J. A., Lin, Q., & Kim, Y. (2022). A measurement invariance analysis of selected Opioid Overdose Knowledge Scale (OOKS) items among bystanders and first responders. PloS one, 17(10), e0271418. https://doi.org/10.1371/journal.pone.0271418

Zhang, K. K., Blum, K. M., Chu, J. J., Sharma, S., Skoracki, R. J., Moore, A. M., Janis, J. E., & Barker, J. C. (2023). Reducing Opioid Overprescribing through Procedure-specific Prescribing Guidelines. Plastic and reconstructive surgery. Global open, 11(1), e4776. https://doi.org/10.1097/GOX.0000000000004776


Peer-Reviewed Journal Article References:
Aaron, R. V., Finan, P. H., Wegener, S. T., Keefe, F. J., & Lumley, M. A. (2020). Emotion regulation as a transdiagnostic factor underlying co-occurring chronic pain and problematic opioid use. American Psychologist, 75(6), 796–810.

Albright, D. L., McDaniel, J. T., Diehr, A. J., Paxton, J., Bresett, J., & Moss, A. (2020). Small area estimation of opioid abuse and comorbid psychological distress among females living in the thirteen Appalachian region states. Traumatology, 26(1), 61–67.

Angier, H., Fleishman, J., Gordon, L., Cohen, D. J., Cantone, R. E., & Bailey, S. R. (2021). Tier-based treatment for opioid use disorder in the primary care setting. Families, Systems, & Health, 39(2), 345–350.

Bello, J. K., Baxley, C., & Weinstock, J. (2021). Preconception health services for women with opioid use disorder (OUD): A review and best practice recommendation. Translational Issues in Psychological Science, 7(2), 154–165.

Bergeria, C. L., Tan, H., Antoine, D., Weerts, E. M., Huhn, A. S., Hobelmann, J. G., & Dunn, K. E. (2022). A double-blind, randomized, placebo-controlled, pilot clinical trial examining buspirone as an adjunctive medication during buprenorphine-assisted supervised opioid withdrawal. Experimental and Clinical Psychopharmacology. Advance online publication.

Bergman, B. G., Ashford, R. D., & Kelly, J. F. (2020). Attitudes toward opioid use disorder medications: Results from a U.S. national study of individuals who resolved a substance use problem. Experimental and Clinical Psychopharmacology, 28(4), 449–461.

Bessen, S., Metcalf, S. A., Saunders, E. C., Moore, S. K., Meier, A., McLeman, B., Walsh, O., & Marsch, L. A. (2019). Barriers to naloxone use and acceptance among opioid users, first responders, and emergency department providers in New Hampshire, USA. International Journal of Drug Policy, 74, 144–151.

Bowen, E. A., & Irish, A. (2020). Trauma and principles of trauma-informed care in the U.S. federal legislative response to the opioid epidemic: A policy mapping analysis. Psychological Trauma: Theory, Research, Practice, and Policy. Advance online publication.

Boyd, T., Stipek, J., Kraft, A., Muskrat, J., Hallgren, K. A., Alexander, C., & Greenfield, B. (2021). Quantifying opioid use disorder Cascade of Care outcomes in an American Indian tribal nation in Minnesota. Drug and Alcohol Dependence, 222, Article 108661.

Brown, R. L., Batty, E., Lofwall, M., Kiviniemi, M., & Kizewski, A. (2022). Opioid use-related stigma and health care decision-making. Psychology of Addictive Behaviors. Advance online publication.

Carpenter, R. W., Lane, S. P., Bruehl, S., & Trull, T. J. (2019). Concurrent and lagged associations of prescription opioid use with pain and negative affect in the daily lives of chronic pain patients. Journal of Consulting and Clinical Psychology, 87(10), 872–886.

Davis, J. P., Prindle, J. J., Eddie, D., Pedersen, E. R., Dumas, T. M., & Christie, N. C. (2019). Addressing the opioid epidemic with behavioral interventions for adolescents and young adults: A quasi-experimental design. Journal of Consulting and Clinical Psychology, 87(10), 941–951.

Edwards, K. A., Vowles, K. E., McHugh, R. K., Venner, K. L., & Witkiewitz, K. (2022). Changes in pain during buprenorphine maintenance treatment among patients with opioid use disorder and chronic pain. Journal of Consulting and Clinical Psychology, 90(4), 314–325.

Fishman, M., Wenzel, K., Vo, H., Wildberger, J., & Burgower, R. (2021). A pilot randomized controlled trial of assertive treatment including family involvement and home delivery of medication for young adults with opioid use disorder. Addiction, 116(3), 548–557.

Hall, N. Y., Le, L., Majmudar, I., & Mihalopoulos, C. (2021). Barriers to accessing opioid substitution treatment for opioid use disorder: A systematic review from the client perspective. Drug and Alcohol Dependence, 221, Article 108651.

Hart, C. L., & Hart, M. Z. (2019). Opioid crisis: Another mechanism used to perpetuate American racism. Cultural Diversity and Ethnic Minority Psychology, 25(1), 6–11.

Hirsh, A. T., Anastas, T. M., Miller, M. M., Quinn, P. D., & Kroenke, K. (2020). Patient race and opioid misuse history influence provider risk perceptions for future opioid-related problems. American Psychologist, 75(6), 784–795.

Hossain, M. A., Asamoah-Boaheng, M., Badejo, O. A., Bell, L. V., Buckley, N., Busse, J. W., Campbell, T. S., Corace, K., Cooper, L. K., Flusk, D., Garcia, D. A., Iorio, A., Lavoie, K. L., Poulin, P. A., Skidmore, B., & Rash, J. A. (2020). Prescriber adherence to guidelines for chronic noncancer pain management with opioids: Systematic review and meta-analysis. Health Psychology, 39(5), 430–451

Jones, A. A., Schneider, K. E., Mahlobo, C. T., Maggs, J. L., Dayton, L., Tobin, K. E., & Latkin, C. A. (2022). Fentanyl overdose concerns among people who inject drugs: The role of sex, racial minority status, and overdose prevention efforts. Psychology of Addictive Behaviors. Advance online publication.

Kurdziel-Adams, G., Macfie, J., Kors, S., Fortner, K. B., Towers, C. V., & Lydic, R. (2020). Opioid use in pregnancy: Borderline features and Hepatitis C virus. Personality Disorders: Theory, Research, and Treatment, 11(3), 222–229.

Latkin, C. A., Dayton, L., Davey-Rothwell, M. A., & Tobin, K. E. (2019). Fentanyl and drug overdose: Perceptions of fentanyl risk, overdose risk behaviors, and opportunities for intervention among people who use opioids in Baltimore, USA. Substance Use & Misuse, 54(6), 998–1006.

Logan, D. E., Lavoie, A. M., Zwick, W. R., Kunz, K., Bumgardner, M. A., & Molina, Y. (2019). Integrating addiction medicine into rural primary care: Strategies and initial outcomes. Journal of Consulting and Clinical Psychology, 87(10), 952–961.

López-Martínez, A. E., Sainero-Tirado, G., Esteve, R., Reyes-Pérez, Á., Ruiz-Párraga, G. T., de la Vega, R., Serrano-Ibáñez, E. R., & Ramírez-Maestre, C. (2022). Does pain catastrophizing and distress intolerance mediate the relationship between PTSD and prescribed opioid misuse in people with chronic noncancer pain? Psychological Trauma: Theory, Research, Practice, and Policy. Advance online publication.

MacLean, R. R., Sofuoglu, M., Stefanovics, E., & Rosenheck, R. (2021). Opioid use disorder with chronic pain increases disease burden and service use. Psychological Services. Advance online publication.

Mahoney, J. J. III, Haut, M. W., Hodder, S. L., Zheng, W., Lander, L. R., Berry, J. H., Farmer, D. L., Marton, J. L., Ranjan, M., Brandmeir, N. J., Finomore, V. S., Hensley, J. L., Aklin, W. M., Wang, G.-J., Tomasi, D., Shokri-Kojori, E., & Rezai, A. R. (2021). Deep brain stimulation of the nucleus accumbens/ventral capsule for severe and intractable opioid and benzodiazepine use disorder. Experimental and Clinical Psychopharmacology, 29(2), 210–215.

Messina, B. G., & Worley, M. J. (2019). Effects of craving on opioid use are attenuated after pain coping counseling in adults with chronic pain and prescription opioid addiction. Journal of Consulting and Clinical Psychology, 87(10), 918–926.

Nalven, T., Spillane, N. S., & Schick, M. R. (2020). Risk and protective factors for opioid misuse in American Indian adolescents. Drug and Alcohol Dependence, 206, Article 107736.

Oliva, E. M., Bowe, T., Tavakoli, S., Martins, S., Lewis, E. T., Paik, M., Wiechers, I., Henderson, P., Harvey, M., Avoundjian, T., Medhanie, A., & Trafton, J. A. (2017). Development and applications of the Veterans Health Administration’s Stratification Tool for Opioid Risk Mitigation (STORM) to improve opioid safety and prevent overdose and suicide. Psychological Services, 14(1), 34–49.

Parent, A. C., Carrigan, M., & Pazda, A. D. (2021). The impact of viewing opioid overdose photos on stigma, desire for social distance, and willingness to help. Stigma and Health. Advance online publication.

Pielech, M., Lunde, C. E., Becker, S. J., Vowles, K. E., & Sieberg, C. B. (2020). Comorbid chronic pain and opioid misuse in youth: Knowns, unknowns, and implications for behavioral treatment. American Psychologist, 75(6), 811–824.

Preis, H., Inman, E. M., & Lobel, M. (2020). Contributions of psychology to research, treatment, and care of pregnant women with opioid use disorder. American Psychologist, 75(6), 853–865.

Prince, M. A., Conner, B. T., Davis, S. R., Swaim, R. C., & Stanley, L. R. (2021). Risk and protective factors of current opioid use among youth living on or near American Indian reservations: An application of machine learning. Translational Issues in Psychological Science, 7(2), 130–140.

Ragsdale, J. M., & Elliott, M. (2022). Opioid addiction, attributions, and stigma: An online vignette experimental study. Stigma and Health, 7(2), 205–213.

Saunders, E., Metcalf, S. A., Walsh, O., Moore, S. K., Meier, A., McLeman, B., Auty, S., Bessen, S., & Marsch, L. A. (2019). “You can see those concentric rings going out”: Emergency personnel’s experiences treating overdose and perspectives on policy-level responses to the opioid crisis in New Hampshire. Drug and Alcohol Dependence, 204, Article 107555.

Scott, K., Murphy, C. M., Yap, K., Moul, S., Hurley, L., & Becker, S. J. (2021). Health professional stigma as a barrier to contingency management implementation in opioid treatment programs. Translational Issues in Psychological Science, 7(2), 166–176.

Sinclair-House, N., Child, J. J., & Crombag, H. S. (2020). Addiction is a brain disease, and it doesn’t matter: Prior choice in drug use blocks leniency in criminal punishment. Psychology, Public Policy, and Law, 26(1), 36–53.

West, A. E., Telles, V., Antony, V., Zeledon, I., Moerner, L., & Soto, C. (2021). An opioid and substance use disorder needs assessment study for American Indian and Alaska Native youth in California. Psychology of Addictive Behaviors. Advance online publication.

Wilson, A. C., Morasco, B. J., Holley, A. L., & Feldstein Ewing, S. W. (2020). Patterns of opioid use in adolescents receiving prescriptions: The role of psychological and pain factors. American Psychologist, 75(6), 748–760.

Wood, C. A., Duello, A., Horn, P., Winograd, R., Jackson, L., Mayen, S., & Wallace, K. (2021). Overdose response training and naloxone distribution among rural first responders. Journal of Rural Mental Health, 45(3), 207–218.

Zegel, M., Rogers, A. H., Vujanovic, A. A., & Zvolensky, M. J. (2021). Alcohol use problems and opioid misuse and dependence among adults with chronic

Additional References:
- Arizona Department of Health Services. (2018). Arizona Opioid Prescribing Guidelines. Arizona Department of Health Services, 10-14, 43-47.

- Boateng, S., Bollinger, A. RN, Blum, J., MD, Casey, J., Cleaver, M. A., Cooke, M., DDS, MD, MPH, Feudtner, C. MD. (9/19/17). Safe Prescribing of Opioids in Pediatric and Adolescent Populations. Commonwealth of Pennsylvania, 1-6.

- Centre for Addiction and Mental Health (CAMH). (2017). Street Fentany. Centre for Addiction and Mental Health, 1-2.

- Commonwealth of Massachusetts. (September 2019). Best Practices in Prescribing Opioids. Commonwealth of Massachusetts Board of Registration in Medicine Quality and Patient Safety Division, 1-20.

- Giroir, B., Dowell, D., MD, MPH, Jones, C., PharmD, DrPH, Compton, W., MD, MPE, Kato, E., MD, MRP, Dubenitz, J., PhD, Ling, S., MD, Foster, D., DO, MS, MPH, Hertz, S., MD, Sokolowska, M., PhD, Steinberg, J., MD, MPH, Vythilingam, M., MD, and Clarke, T., PhD. (October 2019). HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics. U.S. Department of Health and Human Services, 1-6.

- Greenfield, B., Russell, E., Youngdeer, H., Walls, M., & Alexander, C. (December 2019). Reducing opioid overdose deaths in Minnesota: Insights from one tribal nation. National Drug Early Warning System (NDEWS) Minnesota HotSpot Study, 11-21.

- Pence, M. R. (December 30, 2016). Best Practice Guidelines for the Treatment of Opioid Use Disorders. Indiana Family and Social Services Administration, 3-11.

- Sacramento County Department of Health Services. (August 26, 2019). Responding to a Fentanyl Overdose: What California First Responders Need to Know. Sacramento County Department of Health Services, 1-2.

- Soto C, West A, Unger J, et al. (September 2019). Addressing the Opioid Crisis in American Indian & Alaska Native Communities in California: A Statewide Needs Assessment. Institute for Health Promotion & Disease Prevention Research (IPR), 84-108.

- Substance Abuse and Mental Health Services Administration. (2018). SAMHSA Opioid Overdose Prevention Toolkit. HHS Publication No. (SMA) 18-4742. Rockville, MD: Substance Abuse and Mental Health Services
Administration, 5-8, 20.

- Tennessee Department of Health. (January 2020). Tennessee Chronic Pain Guidelines Clinical Practice Guidelines for Outpatient Management of Chronic Non-Malignant Pain. Tennessee Department of Health and the Chronic Pain Guidelines Panel, 1-6, 63.

- U.S. Department of Health and Human Services, Health Resources and Services Administration. (November 2020). Caring for Women with Opioid Use Disorder: A Toolkit for Organization Leaders and Providers. Rockville, Maryland: U.S. Department of Health and Human Services, 10-15.

Test
Table of Contents
Top